AAM
CMD

Advisors Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Advisors Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,019
Closed -$144K – 1606
2020
Q1 		$144K Sell
4,019
-3,914
-49% -$223K ﹤0.01% 1166
2019
Q4 		$562K Sell
7,933
-248
-3% -$18K 0.01% 948
2019
Q3 		$612K Sell
8,181
-427
-5% -$36.2K 0.01% 920
2019
Q2 		$694K Sell
8,608
-289
-3% -$20.3K 0.01% 905
2019
Q1 		$595K Sell
8,897
-4,306
-33% -$326K 0.01% 1021
2018
Q4 		$983K Sell
13,203
-2,989
-18% -$247K 0.02% 770
2018
Q3 		$1.49M Sell
16,192
-1,811
-10% -$172K 0.02% 703
2018
Q2 		$1.77M Sell
18,003
-2,009
-10% -$225K 0.03% 637
2018
Q1 		$2.33M Sell
20,012
-789
-4% -$88.4K 0.04% 554
2017
Q4 		$2.14M Sell
20,801
-6,738
-24% -$671K 0.04% 597
2017
Q3 		$2.59M Sell
27,539
-14,032
-34% -$1.11M 0.04% 528
2017
Q2 		$3.24M Sell
41,571
-1,794
-4% -$135K 0.05% 456
2017
Q1 		$3.47M Sell
43,365
-23,830
-35% -$1.89M 0.06% 448
2016
Q4 		$5.29M Sell
67,195
-423
-0.6% -$32.9K 0.09% 327
2016
Q3 		$5.27M Sell
67,618
-29,464
-30% -$2.14M 0.09% 334
2016
Q2 		$6.67M Buy
+97,082
New +$6.7M 0.11% 278
2016
Q1 		– Sell
-109,407
Closed -$6.8M – 1883
2015
Q4 		$6.8M Sell
109,407
-1,452
-1% -$88.6K 0.11% 267
2015
Q3 		$6.29M Buy
110,859
+2,202
+2% +$117K 0.1% 286
2015
Q2 		$5.83M Buy
108,657
+30,245
+39% +$1.47M 0.08% 338
2015
Q1 		$3.73M Buy
78,412
+7,966
+11% +$353K 0.05% 471
2014
Q4 		$3.05M Buy
70,446
+9,591
+16% +$392K 0.04% 498
2014
Q3 		$2.09M Sell
60,855
-11,008
-15% -$389K 0.03% 603
2014
Q2 		$2.63M Sell
71,863
-9,562
-12% -$324K 0.04% 517
2014
Q1 		$2.75M Sell
81,425
-8,262
-9% -$273K 0.04% 466
2013
Q4 		$3.04M Sell
89,687
-1,873
-2% -$64.9K 0.05% 420
2013
Q3 		$2.92M Buy
91,560
+11,313
+14% +$301K 0.05% 399
2013
Q2 		$1.81M Buy
+80,247
New +$1.74M 0.03% 486

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advisors Asset Management's CMD Position: Q2 2020 in Review

Advisors Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 4,019 shares — an estimated $144K sold.

Advisors Asset Management first reported a position in CMD in Q2 2013 and held it in 27 quarters. The position peaked at $6.8M in Q4 2015. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Advisors Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Advisors Asset Management sold 4,019 Cantel Medical Corporation shares in Q2 2020, an estimated $144K.
  • Advisors Asset Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 27 quarters.
  • Advisors Asset Management's Cantel Medical Corporation position peaked at $6.8M in Q4 2015.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Advisors Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.